Brustkanker is 'n serieuze en potentieel dodeleke ziekte.
't Is de algemeinste kanker bie vrouwlui wereldwied en de twiede veurnaamste oorzaak vaan kankersterfte bie vrouwlui.
Volges de American Cancer Society woorte in 2020 gesjat 276.480 nui gevalle vaan invasieve borstkanker gediagnoseerd bij vrouwlui in de VS, en ongeveer 42.170 vrouwlui in de VS storve aon borstkanker.
't Sterfteciefer vaan borstkanker is evels sinds 1989 gedaald, mèt 'n daling vaan 40% vaan 1989 tot 2017, veural door verbeterings in de vreuge opsporing en behandeling.
't Risico op sterfte aon borstkanker versjèlt aafhankelek vaan factore wie leeftied, stadium bij diagnose en 't soort borstkanker.
Vroege opsporing en behandeling kin de kans op euverleve aonzeenlek verbetere.
van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011, 104 (6): 910-4.
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 2019, 69 (6): 438-451.
Icaza G, Núñez L, Bugueño H: [Epidemiological analysis of breast cancer mortality in women in Chile]. Rev Med Chil. 2017, 145 (1): 106-114.
Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA: Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017, 14 (9): 1137-1143.
Deaths from breast cancer--United States, 1991. MMWR Morb Mortal Wkly Rep. 1994, 43 (15): 273, 279-81.
Kuroishi T, Hirose K, Suzuki T, Tominaga S: Effectiveness of mass screening for breast cancer in Japan. Breast Cancer. 2000, 7 (1): 1-8.
['Disclaimer: medisch']
['Dees website is allein veur educatief en informatieve doele en is gein medisch advies of professionele deenste.']
["De verstrekte informatie moot neet weure gebruuk veur 't diagnosticere of behandele vaan 'n gezondheidsprobleem of -krenkde, en lui die medisch advies wèlle höbbe mote 't vraoge aon 'ne gecertificeerde dokter."]
["Bloadn woarin dat de antwoorden op de vraogen in 't neuraal netwark onnauwkeurig bint."]
["Vraog altied advies aon d'n dokter of aon 'n aander gekwalificeerde gezondheidsdeensverlener euver 'n medische toestand. Vergaet noets professioneel medisch advies of vertraog 't in te vraoge umtot get wat geer op dees website höb geleze. Es geer dink tot geer 'n medisch noodgeval höb, bel 911 of geit nao de naoste spoedeisende hulp. Gein arts-patiënt relatie weurt gecreëerd door dees website of 't gebruuk daovaan. Noch BioMedLib noch zien werknemers, noch eedere medewerker aon dees website, maak 'n verklaoring, expliciet of impliciet, mèt betrekking tot de informatie hei of op 't gebruuk daovaan."]
['Disclaimer: copyright']
["De Digital Millennium Copyright Act vaan 1998, 17 U.S.C. § 512 (de DMCA) zörg veur recourse veur copyright-eigenaere die geluive dat materiaal wat op 't internet versjijnt hun rechte oonder de Amerikaanse copyrightwetgeving schendt. "]
["Es geer good geluif dat content of materiaal wat in verband mèt eus website of deenste besjikbaar is, euvertrejt, kinne geer (of eur agent) us 'n berich sture boebij geer vraogt tot de content of 't materiaal weurt verwijderd of tot d'n toegang weurt geblokkeerd."]
['Aankondiginge mote weure gesjtuurd per e-mail (zuug de sectie "Contact" veur e-mailadres).']
["De DMCA vereis dat d'n aovend vaan vermeinde auteursrechsoortreding de volgende informatie bevat: (1) 'n Besjrieving vaan 't auteursrechsbesjermp werk wat 't oonderwerp is vaan de vermeinde euvertreding; (2) 'n Besjrieving vaan de vermeinde euvertrèkkende content en informatie genóg um us de content te laote opspoore; (3) contactinformatie veur diech, inclusief adres, telefoonnummer en e-mailadres; (4) 'n verklaoring vaan diech tot diech good geluif höbs tot de content op de klaagde meneer neet is geautoriseerd door de auteursrechseigenaer, of d'n agent, of door de werking vaan e wèt; "]
["(5) 'n oetlègk vaan diech, oonder straof vaan meineed, dat de informatie in de melding juus is en dat diech de autoriteit höbs um de auteursrechte die weure gesjend te handhaven;"]
["en (6) 'n fysieke of elektronische handtekening vaan de eigenaer vaan 't auteursrech of 'n persoen die gemachtigd is um namens de eigenaer vaan 't auteursrech te handelen. "]
["Es geer neet alle bovestaonde informatie geit geve, kin 't tot gevolg höbbe tot de behandeling vaan eur klach get later weurt."]
['Contact']
['Bitte schick uns eine E-Mail mit irgendwelchen Fragen/Vorschlägen.']
How deadly is breast cancer?
Breast cancer is a serious and potentially deadly disease.
It is the most common cancer among women worldwide and the second leading cause of cancer death in women.
According to the American Cancer Society, in 20220, an estimated 276,480 new cases of invasive breast cancer were diagnosed in women in the United States, and about 42,170 women in the U.S. died from breast cancer.
However, the death rate from breast cancer has been declining since 1989, with a 40% decrease in the breast cancer death rate from 1989 to 2017, largely due to improvements in early detection and treatment.
The risk of dying from breast cancer varies depending on factors such as age, stage at diagnosis, and the type of breast cancer.
Early detection and treatment can significantly improve the chances of survival.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Zu']
['BioMedLib gebruuk geautomatiseerde computers (machine-learning algoritmes) um vraog-en-antwoord pare te generere.']
['Wir beginnen mit 35 miljoen biomedische publicaties van PubMed/Medline.']
